Chugai Pharmaceutical Co. Ltd. - Total Other Finance Cost

Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.

The item "Total-Other-Finance-Cost" stands at -0.043 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 12/31/2023.

Chugai Pharmaceutical Co. Ltd.'s second quarter result of -0.0063 Billion JPY for the item "Total Other Finance Cost" represents an increase of 8.75 percent compared to it's first quarter result.

Also, Chugai Pharmaceutical Co. Ltd.'s second quarter result of -0.0063 Billion JPY for the item "Total Other Finance Cost" represents an increase of 4.27 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s second quarter result of -0.043 Billion JPY for the item "Total Other Finance Cost" represents an increase of 0.65 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.89 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 1.89 Billion Japanese Yens.
The 3 year change is -0.979 Billion Japanese Yens.
The 5 year change is 0.987 Billion Japanese Yens.
The 10 year change is 0.002 Billion Japanese Yens.

The Serie's long term average value is 0.0017 Billion Japanese Yens. It's latest available value, on 06/30/2025, is -0.0447 Billion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 06/30/2024, to it's latest available value, on 06/30/2025, is +1.89 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 06/30/2023, to it's latest available value, on 06/30/2025, is -2.92 Billion.